SELECTA BIOSCIENCES INC Contracts & Agreements

Second Amendment to Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated August 30, 2024 (Filed With SEC on November 7, 2024)

Amended and Restated 2016 Incentive Award Plan and form of award agreements thereunder (Filed With SEC on August 2, 2024)

Amended and Restated Cartesian Therapeutics, Inc. 2018 Employment Inducement Incentive Award Plan, and forms of award agreements thereunder (Filed With SEC on August 2, 2024)

Non-Employee Director Compensation Program (Filed With SEC on August 2, 2024)

Securities Purchase Agreement, dated as of July 2, 2024, by and between Cartesian Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on July 2, 2024)

Form of Registration Rights Agreement (Filed With SEC on July 2, 2024)

First Amendment to Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated May 7, 2024 (Filed With SEC on May 8, 2024)

Employment Agreement, dated as of March 26, 2024, by and between the Registrant and Christopher Jewell, Ph.D (Filed With SEC on April 1, 2024)

Employment Agreement, dated as of March 28, 2024, by and between the Registrant and Metin Kurtoglu, M.D., Ph.D (Filed With SEC on April 1, 2024)

Description of Securities (Filed With SEC on March 7, 2024)

Non-Employee Director Compensation Program (Filed With SEC on March 7, 2024)

Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated May 11, 2018 (Filed With SEC on March 7, 2024)

First Amendment to Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated March 22, 2021 (Filed With SEC on March 7, 2024)

Second Amendment to Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated May 3, 2021 (Filed With SEC on March 7, 2024)

Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated February 28, 2024 (Filed With SEC on March 7, 2024)

Amendment No. 1 to License and Development Agreement, dated as of October 31, 2023, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (Filed With SEC on March 7, 2024)

Patent License Agreement, between Cartesian Therapeutics, Inc. and the U.S. Department of Health and Human Services, as represented by the National Cancer Institute of the... (Filed With SEC on March 7, 2024)

Patent License Agreement by and between Biogen MA, Inc. and Cartesian Therapeutics, Inc., dated September 8, 2023 (Filed With SEC on March 7, 2024)

License and Development Agreement, dated January 8, 2023, by and between Selecta Biosciences, Inc. and Audentes Therapeutics, Inc (Filed With SEC on March 7, 2024)

Fourth Amendment to Loan and Security Agreement, dated March 31, 2023, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a lender, and Silicon... (Filed With SEC on April 4, 2023)

Form of Amendment No. 1 to Common Stock Purchase Warrant by and between Selecta Biosciences, Inc. and certain Directors, dated December 20, 2022 (Filed With SEC on March 2, 2023)

Description of Securities (Filed With SEC on March 2, 2023)

Non-Employee Director Compensation Program (Filed With SEC on March 2, 2023)

Employment Agreement, dated as of November 9, 2022, by and between the Registrant and Blaine Davis (Filed With SEC on March 2, 2023)

Separation and Release Agreement, dated November 23, 2022, by and between the Registrant and Kevin Tan (Filed With SEC on March 2, 2023)

First Amendment to Lease by and between BRE-BMR Grove LLC and Selecta Biosciences, Inc. dated September 1, 2022 (Filed With SEC on November 3, 2022)

Third Amendment to Loan and Security Agreement, dated September 20, 2022, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a Lender, and Silicon... (Filed With SEC on November 3, 2022)

Underwriting Agreement, dated April 6, 2022, by and between Selecta Biosciences, Inc. and SVB Securities LLC, as representative of the several underwriters named therein (Filed With SEC on April 7, 2022)

Form of Warrant (Filed With SEC on April 7, 2022)

Second Amendment to Loan and Security Agreement, dated March 21, 2022, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a lender, and Silicon... (Filed With SEC on March 22, 2022)

Description of Securities (Filed With SEC on March 10, 2022)

Employment Agreement, dated September 3, 2021, by and between Selecta Biosciences, Inc. and Kevin Tan (Filed With SEC on November 9, 2021)

Non-Employee Director Compensation Program (Filed With SEC on November 9, 2021)

First Amendment to Loan and Security Agreement, dated September 7, 2021, by and among Selecta Biosciences, Inc., Oxford Finance LLC, and Silicon Valley Bank (Filed With SEC on November 9, 2021)

Sales Agreement, dated October 25, 2021, between Selecta Biosciences, Inc. and SVB Leerink LLC (Filed With SEC on October 25, 2021)

Promotion Letter dated May 11, 2021, between Selecta Biosciences, Inc. and Ann K. Donohue (Filed With SEC on August 12, 2021)

Non-Employee Director Compensation Program (Filed With SEC on May 13, 2021)

Description of Securities (Filed With SEC on March 12, 2021)

Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ), as amended on November 4, 2020 (Filed With SEC on November 5, 2020)

Employment Agreement, dated July 31, 2020, by and between Selecta Biosciences, Inc. and Peter G. Traber, M.D (Filed With SEC on November 5, 2020)

Form of Warrant to Purchase Stock, dated August 31, 2020, issued by Selecta Biosciences, Inc. to Oxford Finance LLC and Silicon Valley Bank, together with a schedule of warrants (Filed With SEC on September 3, 2020)

Letter agreement, dated August 31, 2020, among Selecta Biosciences, Inc., Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on September 3, 2020)

Loan and Security Agreement, dated August 31, 2020, between Selecta Biosciences, Inc., Oxford Finance LLC, as Collateral Agent and as a lender, and Silicon Valley Bank, as a lender (Filed With SEC on September 3, 2020)

Registration Rights Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (Filed With SEC on August 6, 2020)

Fifth Amendment to Exclusive Patent License Agreement, dated as of May 15, 2020, by and between the Registrant and the Massachusetts Institute of Technology (Filed With SEC on August 6, 2020)

License and Development Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (Filed With SEC on August 6, 2020)

Stock Purchase Agreement, dated as of June 11, 2020, by and between the Registrant and Swedish Orphan Biovitrum AB (Publ) (Filed With SEC on August 6, 2020)

Open Market Sale Agreement, dated as of August 6, 2020, by and between Selecta Biosciences, Inc. and Jefferies LLC (Filed With SEC on August 6, 2020)

Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Stephen Smolinski (Filed With SEC on June 25, 2020)

Transition Agreement and Release, dated June 25, 2020, between Selecta Biosciences, Inc. and Elona Kogan (Filed With SEC on June 25, 2020)

Non-Employee Director Compensation Program (Filed With SEC on May 7, 2020)

Description of Securities (Filed With SEC on March 12, 2020)

Fourth Amendment to Exclusive Patent License Agreement, entered into on December 13, 2019, by and between the Massachusetts Institute of Technology and the Registrant (Filed With SEC on March 12, 2020)

Form of Common Stock Purchase Warrant, dated December 23, 2019 (Filed With SEC on December 26, 2019)

Form of Pre-Funded Common Stock Purchase Warrant, dated December 23, 2019 (Filed With SEC on December 26, 2019)

Registration Rights Agreement, dated December 23, 2019, by and among Selecta Biosciences, Inc. and the Investors named therein (Filed With SEC on December 26, 2019)

Securities Purchase Agreement, dated December 18, 2019, by and among Selecta Biosciences, Inc. and the Investors named therein (Filed With SEC on December 26, 2019)

Employment Agreement, dated August 12, 2019, by and between Selecta Biosciences, Inc. and Bradford D. Dahms (Filed With SEC on November 8, 2019)

Feasibility Study and License Agreement by and between Asklepios BioPharmaceutical, Inc. and Selecta Biosciences, Inc. dated August 6, 2019 (Filed With SEC on November 8, 2019)

Lease Agreement by and between BRE-BMR Grove LLC and Selecta Biosciences, Inc. dated July 23, 2019 (Filed With SEC on November 8, 2019)

Stock Purchase Agreement, dated August 19, 2019, by and among Selecta Biosciences, Inc. and the Investors named therein (Filed With SEC on August 20, 2019)

Employment Agreement, dated June 21, 2019, by and between Selecta Biosciences, Inc. and Alison Schecter, M.D (Filed With SEC on August 8, 2019)

Employment Agreement, dated March 19, 2019, between Selecta Biosciences, Inc. and Elona Kogan (Filed With SEC on May 9, 2019)

Employment Offer Letter, dated July 29, 2016, between Selecta Biosciences, Inc. and Ann K. Donohue, and Promotion Letter dated November 30, 2017 (Filed With SEC on May 9, 2019)

Amendment to Consulting Agreement, dated December 31, 2018, to Consulting Agreement by and between Registrant and Omid Farokzhad, dated May 30, 2018 (Filed With SEC on March 15, 2019)

Transition Agreement and Release, dated March 6, 2019, between Selecta Biosciences, Inc. and John Leaman, M.D (Filed With SEC on March 8, 2019)

Underwriting Agreement, dated January 23, 2019, between the Company and Stifel, Nicolaus & Company, Incorporated, as representative of the several underwriters named therein (Filed With SEC on January 24, 2019)

Separation Agreement and Release, dated as of December 1, 2018, by and between Selecta Biosciences, Inc. and Werner Cautreels (Filed With SEC on December 3, 2018)

Consulting Agreement, dated as of December 1, 2018, by and between Selecta Biosciences, Inc. and Werner Cautreels (Filed With SEC on December 3, 2018)

Selecta Biosciences, Inc. 2018 Employment Inducement Incentive Award Plan, and forms of award agreements thereunder (Filed With SEC on September 27, 2018)

Employment Agreement, dated September 25, 2018, by and between Selecta Biosciences, Inc. and Carsten Brunn, Ph.D (Filed With SEC on September 27, 2018)

Consulting Agreement, dated May 30, 2018, between Selecta Biosciences, Inc. and Omid Farokhzad, M.D (Filed With SEC on August 8, 2018)

Non-Employee Director Compensation Program (Filed With SEC on August 8, 2018)

Transition and Consulting Agreement, dated as of December 18, 2017, by and between Selecta Biosciences, Inc. and Peter Keller (Filed With SEC on December 19, 2017)

Employment Agreement, dated October 26, 2017, by and between the Registrant and John Leaman, M.D (Filed With SEC on November 7, 2017)

Employment Agreement, dated October 26, 2017, by and between the Registrant and Stephen Smolinski (Filed With SEC on November 7, 2017)

Employment Agreement, dated as of October 26, 2017, by and between Selecta Biosciences, Inc. and John H. Leaman, M.D (Filed With SEC on October 26, 2017)

Loan and Security Agreement, dated September 12, 2017, between Selecta Biosciences, Inc. and Silicon Valley Bank (Filed With SEC on September 13, 2017)

AMENDED & RESTATED LICENSE AGREEMENT (Filed With SEC on August 11, 2017)

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with... (Filed With SEC on August 11, 2017)

OPEN MARKET SALE AGREEMENTSM (Filed With SEC on August 11, 2017)

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANT (Filed With SEC on June 28, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 28, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 28, 2017)

PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT - EXCLUSIVE This Agreement is based on the model Patent License Exclusive Agreement adopted by the U.S. Public Health Service (PHS)... (Filed With SEC on May 11, 2017)

STOCK PURCHASE AGREEMENT (Filed With SEC on December 14, 2016)

THIRD AMENDMENT (Filed With SEC on December 14, 2016)

SPARK THERAPEUTICS, INC.3737 MARKET STREET, SUITE 1300"PHILADELPHIA, PA 19104P215.220.9300SPARKTX.COM (Filed With SEC on December 14, 2016)

FOURTH AMENDMENT TO LEASE (Filed With SEC on September 14, 2016)

SELECTA BIOSCIENCES, INC. 2008 Stock Incentive Plan (Filed With SEC on June 20, 2016)

SELECTA BIOSCIENCES, INC. Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on June 8, 2016)

FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on June 8, 2016)

SELECTA BIOSCIENCES, INC. 2016 INCENTIVE AWARD PLAN ARTICLE I. PURPOSE (Filed With SEC on June 8, 2016)

SELECTA BIOSCIENCES, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE (Filed With SEC on June 8, 2016)

SELECTA BIOSCIENCES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on June 8, 2016)

Summary of Oral Agreement between Dr. Omid Farokhzad and Selecta Biosciences, Inc. (Filed With SEC on June 8, 2016)

Employment Agreement (Filed With SEC on June 8, 2016)

SELECTA BIOSCIENCES, INC. INDEPENDENT DIRECTOR CONSULTING AGREEMENT (George R. Siber, M.D.) (Filed With SEC on June 8, 2016)

Category

Industry

Companies

Contracts

SELECTA BIOSCIENCES INC Contracts & Agreements